Three dimensional conformal radiation therapy in prostate adenocarcinoma: Survival and rectal toxicity

Journal of Cancer Research and Therapeutics

Volumn 1, Issue 1, 2005, Pages 34-37

  Kannan, V ^a   Sathiyanarayanan, V K ^a   Sagde, S ^a   Anand, Vivek ^a   Almel, Sachin ^a   Kapadia, Asha ^a   Srinivas, V ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Conformal Radiation; Doses collection; Prostate cancer

Indexed keywords

ACUTE TOXICITY; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HOSPITAL; HUMAN; IMMOBILIZATION; LEG; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; ORGAN; PELVIS; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; RADIATION BEAM; RADIATION DOSE; RADIATION HAZARD; RECTUM DISEASE; RISK ASSESSMENT; THREE DIMENSIONAL CONFORMAL RADIATION THERAPY; TOXICITY;

EID: 19044391347     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.16088     Document Type: Article

References (19)

1. Fowler JF. Potential for increasing the differential response between tumors and normal tissues: Can proliferation rate be used? Int J Radiat Oncol Biol Phys 1986;12:641-5.
2. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988;15:1299-1305.
3. Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization and future directions. Int J Radiat Oncol Biol Phys 1998;41:501-10.
4. Zelefsky MJ, Fuks Z, Wolfe T, et al. Locally advanced prostatic cancer: Long term toxicity outcome after three - dimensional conformal radiation therapy - a dose escalation study. Radiology 1998;209:169-74.
5. Lawton CA, Won M, Pilepich MV, et al. Long term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991;21:935-9.
6. Yeole BB. Trends and predictions of cancer incidence cases by site and sex for Mumbai. Ind J Cancer 1999;36:163-78.
7. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, CA. Cancer J Clin 1997;47:5-27.
8. Middleton RG, Thompson IM, Austenfeld MS, et al. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 1995;154:2144-8.
9. Martinez AA, Gonzalez JA, Chung AK, et al. A comparison of external beam therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged and treated at a single institution. Cancer 2000;88:425-32.
10. Lyons JA, Kupelian PA, Mohan DS, et al. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 2000;55:85-90.
11. Smit WGJM, Helle PA, van Putte WLJ, et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 1990;18:23-9.
12. Vijayakumar S, Hellman S. Advances in radiation oncology. Lancet. 1997;349:1-3.
13. Hanks GE, Schultheiss TE, Hanlen AL, et al. Optimization of conformal radiation treatment of prostate cancer: Report of a dose-escalation study. Int J Radiat Oncol Biol Phys 1997;37:543-50.
14. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
15. Hanks GE, Hanlon AL, Pinover WH, et al. Survival advantage for prostate cancer patients treated with high dose three-dimensional conformal radiotherapy. Cancer J Sci Am 1999;5:152-8.
16. Pollock A, Zagars GK. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:1011-8.
17. Michalski JM, Winter K, Purdy JA, et al. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys 2004:58:735-42.
18. Beckendorf V, Guerif S, LePrise E, et al. The GETUG 70 Gy Vs 80 Gy randomized trial for localised prostate cancer: Feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 2004:60:1056-65.
19. Zelefsky MJ, Leibel SA, Fuks Z. Letters to the editor. Int J Radiat Oncol Biol Phys 1999;43:235.